Regeneron Pharmaceuticals (REGN)
Working Capital Ratio
30.95%
Quarterly · Period ending:

REGN Working Capital Ratio
Latest reported30.95%period ending
Latest reported30.95%period ending
REGN Quarterly Working Capital Ratio (81.10% → 30.95%)
Quarterly working capital ratio
High-resolution chart · PNG
REGN working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 71.3231% | |
| 78.1193% | |
| 57.7873% | |
| 57.4429% | |
| 61.5668% | |
| 46.2237% | |
| 43.5766% | |
| 48.5863% | |
| 48.2833% | |
| 44.4072% | |
| 53.2186% | |
| 49.0148% | |
| 48.3949% | |
| 51.6729% | |
| 52.791% | |
| 57.2556% | |
| 58.7059% | |
| 48.1797% | |
| 53.0523% | |
| 49.3874% | |
| 51.7588% | |
| 32.4826% | |
| 38.6994% | |
| 22.2372% | |
| 27.9376% | |
| 28.1069% | |
| 36.1996% | |
| 31.3142% | |
| 31.7881% | |
| 31.6981% | |
| 66.9218% | |
| 79.587% | |
| 73.1796% | |
| 77.9249% | |
| 81.8182% | |
| 82.9502% | |
| 85.7406% | |
| 87.7005% | |
| 90.614% | |
| 94.2982% | |
| 94.8785% | |
| 81.1024% |